How much does Mydriacyl cost?

Pricing for Mydriacyl varies by insurance plan, dose, and pharmacy. Our database does not show a fixed cost because prices change faster than we can verify. For current pharmacy prices, check your insurance's formulary tier (in the prior-authorization section), use the GoodRx or Cost Plus Drugs deep links on this page, or ask your pharmacist to run a test claim. If a copay card is listed, it usually drops the out-of-pocket significantly for commercial insurance.

Does Mydriacyl need prior authorization?

Mydriacyl appears on 1 payer formulary in our database. PA requirements vary by payer — see the prior-authorization table on this page for specifics. In general, specialty and brand-name drugs are more likely to require PA than generic equivalents.

Is there a copay card or patient assistance program for Mydriacyl?

We haven't verified an active copay card or PAP for Mydriacyl in our current data. Check NeedyMeds or RxAssist for independent directories, or submit what you find via our "Report a broken link" form.

What is Mydriacyl used to treat?

Mydriacyl (generic: tropicamide) is indicated for Eye Exam, Routine Eye Examination, Eye Examination. Click any condition name on this page for more detail.

Does Mydriacyl have a generic version?

The generic name for Mydriacyl is tropicamide. Whether a generic is currently available depends on patent status — check the FDA Orange Book or ask your pharmacist. Generics are often substantially cheaper than brand-name drugs.

Mydriacyl

Generic: tropicamide

Verified·Apr 23, 2026

Manufacturer: Alcon
NDC: 0065-0355
RxCUI: 208660
Route: OPHTHALMIC
ICD-10 indication: Z01.00

Affordability Check

How much will you actually pay for Mydriacyl?

In 30 seconds, see every legitimate way to afford Mydriacyl — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About Mydriacyl

What is this medication?

Mydriacyl is an ophthalmic solution primarily used to enlarge the pupil of the eye during a medical examination. It contains the active ingredient tropicamide, which belongs to a class of drugs known as anticholinergics. By blocking certain nerve impulses to the muscles of the iris, the medication allows eye care professionals to get a clear and detailed view of the internal structures of the eye, such as the retina and the optic nerve.

In addition to pupil dilation, this medication is used to temporarily relax the focusing muscles within the eye. This process, known as cycloplegia, is helpful for determining an accurate lens prescription, particularly in children or patients who may have difficulty controlling their eye focus. The effects typically begin within a few minutes of application and can last for several hours, during which time a patient may experience increased sensitivity to light and temporary blurred vision.

Copay & patient assistance

Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program for more details.

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

Cost Plus Drug Company

Mark Cuban's transparent-pricing pharmacy — manufacturer cost + 15% markup + $5 dispensing fee. No insurance needed. Search alphabetically for tropicamide.

Browse Cost Plus medications →

GoodRx

Compare local pharmacy prices with GoodRx coupons. Use the price with your insurance or without — whichever is cheaper.

Lookup Mydriacyl →

NeedyMeds

Independent nonprofit directory of patient assistance programs, copay cards, and charity co-pay foundations.

Search for tropicamide →

RxAssist

PAP directory maintained by Volunteers in Health Care at Brown University. Free, no ads.

Search PAPs →

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Prescribing information

From the FDA-approved label for Mydriacyl. Official source: DailyMed (NLM) · Label effective Dec 22, 2022

Indications and usage

INDICATIONS AND USAGE For mydriasis and cycloplegia for diagnostic procedures.

Dosage and administration

DOSAGE AND ADMINISTRATION For refraction, instill one or two drops of 1% solution in the eye(s), repeated in five minutes. If patient is not seen within 20 to 30 minutes, an additional drop may be instilled to prolong mydriatic effect. For examination of fundus, instill one or two drops of 0.5% solution 15 or 20 minutes prior to examination. Individuals with heavily pigmented irides may require higher strength or more doses. Mydriasis will reverse spontaneously with time, typically in 4 to 8 hours. However, in some cases, complete recovery may take up to 24 hours.

Contraindications

CONTRAINDICATIONS Contraindicated in persons showing hypersensitivity to any component of this preparation.

Warnings

WARNINGS FOR TOPICAL OPHTHALMIC USE ONLY. NOT FOR INJECTION. This preparation may cause CNS disturbances which may be dangerous in pediatric patients. The possibility of psychotic reactions and behavioral disturbances due to hypersensitivity to anticholinergic drugs should be considered. Mydriatics may produce a transient elevation of intraocular pressure. Remove contact lenses before using.

Drug interactions

Drug Interactions Tropicamide may interfere with the antihypertensive action of carbachol, pilocarpine, or ophthalmic cholinesterase inhibitors.

Adverse reactions

ADVERSE REACTIONS Ocular: Transient stinging, blurred vision, photophobia and superficial punctate keratitis have been reported with the use of tropicamide. Increased intraocular pressure has been reported following the use of mydriatics. Non-Ocular: Dryness of the mouth, tachycardia, headache, allergic reactions, nausea, vomiting, pallor, central nervous system disturbances and muscle rigidity have been reported with the use of tropicamide. Psychotic reactions, behavioral disturbances, and vasomotor or cardiorespiratory collapse in children have been reported with the use of anticholinergic drugs.

Use in pregnancy

Pregnancy Animal reproduction studies have not been conducted with tropicamide. It is also not known whether tropicamide can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Tropicamide should be given to a pregnant woman only if clearly needed.

Label text is reproduced as-is from the FDA-approved label. We do not paraphrase, summarize, or omit. Content above is for informational purposes only and is not medical advice. Always consult your prescribing clinician or pharmacist before making decisions about your medication.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Prior authorization & coverage

Payer	PA	Step therapy	Copay tier
— Medicare Part D	—	—	—

Payer

Step therapy

Copay tier

—

Medicare Part D

—

Related drugs

How this page is sourced

Drug identity verified against openFDA NDC Directory.
Label text (when shown) originates from NLM DailyMed.
Copay and assistance URLs verified periodically; if you hit a broken link, tell us.